CE Holdings Co., Ltd. (4320.T)
JPY 550.0
(0.18%)
JPY 550.0
(0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 795.81 Million | 1.55 Billion | 1 Billion | 912.57 Million | 324.05 Million | 1.27 Billion |
| Net Income | 1.26 Billion | 1.06 Billion | 1 Billion | 360.73 Million | 984.38 Million | 537.24 Million |
| Depreciation & Amortization | 439.36 Million | 369.77 Million | 347.3 Million | 440.04 Million | 208.28 Million | 166.08 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -466.67 Million | 497.14 Million | -229.24 Million | 572.87 Million | -642.25 Million | 582.04 Million |
| Other non-cash items | -439.18 Million | -382.72 Million | -115.08 Million | -461.08 Million | -226.35 Million | -6.48 Million |
| Investing Cash Flow | -861.71 Million | -763.83 Million | -109.38 Million | -68.23 Million | -493.01 Million | -269.19 Million |
| Investments in PPE | -842.16 Million | -1.5 Billion | -390.17 Million | -345.11 Million | -468.03 Million | -283.48 Million |
| Acquisitions | 1.87 Million | 543.69 Million | 269.14 Million | 213.5 Million | 7.81 Million | 17.95 Million |
| Investment purchases | -17.58 Million | -5.62 Million | -14.26 Million | -2.6 Million | -26.3 Million | -53.84 Million |
| Sales/Maturities of investments | 26.47 Million | 194.02 Million | 22.8 Million | 10.11 Million | 1.19 Million | 55.6 Million |
| Other Investing Activities | -30.31 Million | 9.12 Million | 3.11 Million | 55.85 Million | -7.68 Million | -5.42 Million |
| Financing Cash Flow | -754.5 Million | 306.64 Million | -838.45 Million | 573.79 Million | -378.73 Million | -258.34 Million |
| Debt repayment | -572 Million | -673.27 Million | -731.87 Million | -698.99 Million | -271.49 Million | -254.07 Million |
| Dividends payments | -180.69 Million | -119.74 Million | -101.85 Million | -102.25 Million | -93.95 Million | -89.35 Million |
| Common Stock Repurchased | -99.96 Million | - | - | -99.96 Million | -30 Thousand | -16.23 Million |
| Common Stock Issuance | 39.05 Million | 45.22 Million | 21.05 Million | 14.97 Million | 6.88 Million | 101.31 Million |
| Other Financing Activities | 59.1 Million | 1.05 Billion | -25.76 Million | 1.46 Billion | -20.14 Million | -1000.00 |
| Accounts receivables | -893.49 Million | 215.86 Million | -234.72 Million | 1.23 Billion | -1.26 Billion | 544.38 Million |
| Accounts payables | 176.68 Million | -19.34 Million | 269.55 Million | -557.01 Million | 353.38 Million | 123.31 Million |
| Inventory | 114.38 Million | 312.19 Million | -258.16 Million | -122.38 Million | 237.34 Million | -157.27 Million |
| Other working capital | 135.74 Million | -11.57 Million | -5.9 Million | 16.53 Million | 30.06 Million | 739.31 Million |
| Cash at beginning of period | 3.95 Billion | 2.86 Billion | 2.8 Billion | 1.39 Billion | 1.93 Billion | 1.18 Billion |
| Cash at end of period | 3.13 Billion | 3.95 Billion | 2.86 Billion | 2.8 Billion | 1.39 Billion | 1.93 Billion |
| Capital Expenditure | -842.16 Million | -1.5 Billion | -390.17 Million | -345.11 Million | -468.03 Million | -283.48 Million |
| Effect of forex changes on cash | -1000.00 | -1000.00 | - | 2000.00 | - | -2000.00 |
| Net cash flow / Change in cash | -820.4 Million | 1.09 Billion | 56.25 Million | 1.41 Billion | -547.69 Million | 751.34 Million |
| Free Cash Flow | -46.34 Million | 45.63 Million | 613.91 Million | 567.46 Million | -143.97 Million | 995.4 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 326 Million | 45 Million | 167 Million | 1.26 Billion | 26 Million | 396 Million |
| Depreciation & Amortization | - | 108.4 Million | 139.8 Million | 439.36 Million | 104.03 Million | 99.01 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -466.67 Million | - | - |
| Other non-cash items | -326 Million | -45 Million | -167 Million | -439.18 Million | -26 Million | -396 Million |
| Investing Cash Flow | - | - | - | -861.71 Million | - | - |
| Investments in PPE | - | - | - | -842.16 Million | - | - |
| Acquisitions | - | - | - | 1.87 Million | - | - |
| Investment purchases | - | - | - | -17.58 Million | - | - |
| Sales/Maturities of investments | - | - | - | 26.47 Million | - | - |
| Other Investing Activities | - | - | - | -30.31 Million | - | - |
| Financing Cash Flow | - | - | - | -754.5 Million | - | - |
| Debt repayment | - | - | - | -572 Million | - | - |
| Dividends payments | - | - | - | -180.69 Million | - | - |
| Common Stock Repurchased | - | - | - | -99.96 Million | - | - |
| Common Stock Issuance | - | - | - | 39.05 Million | - | - |
| Other Financing Activities | - | - | - | 59.1 Million | - | - |
| Accounts receivables | - | - | - | -893.49 Million | - | - |
| Accounts payables | - | - | - | 176.68 Million | - | - |
| Inventory | - | - | - | 114.38 Million | - | - |
| Other working capital | - | - | - | 135.74 Million | - | - |
| Cash at beginning of period | - | 3.13 Billion | 3.68 Billion | 3.95 Billion | 3.22 Billion | 2.39 Billion |
| Cash at end of period | - | 1.98 Billion | 3.13 Billion | 3.13 Billion | 3.68 Billion | 3.22 Billion |
| Capital Expenditure | - | - | - | -842.16 Million | - | - |
| Effect of forex changes on cash | - | - | - | -1000.00 | - | - |
| Net cash flow / Change in cash | - | -1.15 Billion | -547.22 Million | -820.4 Million | 463.77 Million | 821.76 Million |
| Free Cash Flow | - | 216.8 Million | 279.61 Million | -46.34 Million | 208.06 Million | 198.03 Million |
PRIMESECU
AUROPHARMA
3075
060280
VEOEY
JASH